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The microbes that accompany the etiologic agent of 
cholera, Vibrio cholerae, are only now being deﬁ  ned. In this 
study, spirochetes from the genus Brachyspira were identi-
ﬁ  ed at high titers in more than one third of cholera patients 
in Bangladesh. Spirochetosis should now be tracked in the 
setting of cholera outbreaks.
C
holera in humans results in profuse, watery diarrhea 
that can lead to severe dehydration and death (1). The 
infection begins with ingestion of Vibrio cholerae from 
contaminated water, after which expression of cholera tox-
in induces a ﬂ  uid loss that may reach 1 liter/hour. Cholera 
is an underreported disease in the developing world, and 
the true incidence may reach 2 million cases/year (2).
Because anecdotal evidence has indicated frequent 
cholera and intestinal spirochetosis coinfection in Ban-
gladesh, we studied both diseases in this study. Intestinal 
spirochetosis has negative effects on domestic swine and 
poultry industries (3). In humans, 1%–64% of colonic 
specimens demonstrate intestinal spirochetosis, with the 
highest prevalence in developing countries and immuno-
compromised populations (4). The etiologic agents of intes-
tinal spirochetosis are members of the genus Brachyspira 
(formerly Serpulina and Treponema). B. pilosicoli isolated 
from humans cause disease in pigs and in chicken models 
of infection (5,6). B. aalborgi isolated from humans do not 
colonize animals (7). Surveillance of intestinal spirocheto-
sis requires molecular tools because culture has limited 
sensitivity caused by the fastidious nature of Brachyspira 
spp. (8). Patients with symptomatic intestinal spirochetosis 
have chronic diarrhea or soft feces (4,9,10); these clini-
cal signs may resolve with antimicrobial drug therapy (9). 
Histologic analysis of intestinal biopsy specimens showed 
densely packed spirochetes attached by 1 end to colonic 
epithelium, forming a false brush border (11). Invasion of 
colonic epithelial cells and bleeding may occur (4,12). Vir-
ulence mechanisms remain poorly understood. Research on 
a vaccine to protect pigs against intestinal spirochetosis has 
begun. However, there is no vaccine for protection against 
intestinal spirochetosis in humans.
Co-infection of cholera patients with additional 
pathogens has focused on enterotoxigenic Escherichia 
coli (ETEC); 13% of cholera patients in Bangladesh are 
co-infected with ETEC (13). The potential for pathogenic 
synergy between V. cholerae and other pathogens has been 
proposed but not investigated.
The Study
We deﬁ  ned the frequent presence of spirochetes in fe-
ces of patients with cholera. A 3-step method was used to 
establish the distribution of spirochetes in rice-water stool: 
1) the presence of spirochetes in rice-water stool was de-
termined by using dark-ﬁ  eld microscopy; 2) the diversity 
of Brachyspira spp. within a subset of these patients was 
quantiﬁ  ed by 16S rDNA analysis; and 3) the genetic diver-
sity within the most abundant species was determined by 
analysis of NADH oxidase (nox).
Rice-water stool samples were collected from symp-
tomatic cholera patients (>15 years of age with no history 
of antimicrobial drug therapy) during the spring cholera 
outbreak of 2006 in Dhaka, Bangladesh, at the Interna-
tional Centre for Diarrheal Disease Research, Bangladesh, 
as part of a larger study (14). Samples were examined by 
dark-ﬁ  eld microscopy for V. cholerae and other bacteria, 
and the presence of V. cholerae, lytic vibriophage, and 
ETEC was determined by using standard methods (14). 
Samples were preserved at 4°C in formalin, or cell pel-
lets were resuspended in phosphate-buffered saline and 
15% glycerol and stored at –80°C. Analysis showed that 
36% (23/64) of samples that were positive for only V. 
cholerae also harbored spirochetes (online Technical Ap-
pendix, panels A–F, available from www.cdc.gov/EID/
content/15/4/571-Techapp.pdf). Spirochetes were also 
found in 4/11 and 5/15 samples that harbored ETEC alone 
or both ETEC and V. cholerae, respectively. When we 
removed ETEC-positive samples as potential confound-
ers, the presence of spirochetes was independent of lytic 
vibriophage in V. cholerae–positive stool samples (online 
Technical Appendix, panel G), which is in contrast to 
the documented trend concerning non–V. cholerae bac-
teria in rice-water stool (14). The ratio of spirochetes to 
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In the second step, 10 samples were chosen for mo-
lecular analysis on the basis of a large amount of spiro-
chetes. Samples were heated (99°C for 10 min), and 
standard PCR for a diagnostic segment of the 16S rDNA 
gene (15) was performed by using genus Brachyspira–
speciﬁ  c primers (5′-GTCTTAAGCATGCAAGTC-3′ and 
5′-AACAGGCTAATAGGCCG-3′). Products were cloned 
and sequenced bidirectionally (GenBank accession nos. 
FJ599620–FJ599639). B. pilosicoli was the most common 
species, found in all 10 samples (online Technical Appendix, 
panel I). B. aalborgi was the second most common species (7 
samples). A second set of panspeciﬁ  c 16S rDNA degenerate 
primers (5′-GTTTGATYCTGGCTYAGARCKAACG-3′ 
and 5′-CCSSTACGGMTACCTTGTTACG-3′) conﬁ  rmed 
the presence of Brachyspira spp. and suggested that spi-
rochetes of other genera were not present. The added reso-
lution of nox analysis also identiﬁ  ed B. hyodysenteriae at 
lower abundance.
Culture, puriﬁ  cation, and microscopy of B. pilosicoli 
from glycerol stocks was used to cross-validate the mo-
lecular approach. Standard fastidious anaerobe agar (FAA) 
supplemented with bovine blood (10%), spectinomycin 
(400 μg/mL), and polymyxin B (5 μg/mL) was determined 
empirically to be the optimal medium for isolation of spiro-
chetes. Dilutions of glycerol stocks from each patient were 
plated on FAA agar; single colonies were best obtained with 
an FAA overlay. Plates were incubated for 21 days at 37°C 
in an atmosphere of 94% H2 and 6% CO2. Most colonies 
gave rise to sigmoidal spiral cell morphotypes similar to 
the morphotype of the American Type Culture Collection 
(ATCC) (Manassas, VA, USA) control strain for B. pilosi-
coli. Additional controls were ATCC B. hyodysenteriae, 
Helicobacter pylori, and Borrelia burgdorferi. Subsequent 
molecular analysis of patient isolates conﬁ  rmed them as 
B. pilosicoli. Consistent with previous studies, B. aalborgi 
was not cultured from patient samples.
In the third step, 5 samples were analyzed by us-
ing  nox sequence comparisons that yield higher phy-
logenetic resolution. DNA was extracted and a nox 
segment was ampliﬁ   ed by using degenerate primers 
(5′-GCYGGHACATGGGCDGCAAAAAC-3′ and 5′-
CAAATACRCAAATAGCRTTAG-3′). Products were 
cloned and sequenced bidirectionally (GenBank acces-
sion nos. FJ599589–FJ599619). B. pilosicoli was the most 
common nox sequence found. A phylogenetic tree (Figure) 
demonstrated that individual patients harbored clonal lines 
of B. pilosicoli (patients B, D, and E) or more diverse strains 
(patient A). Overall, B. pilosicoli strains found in cholera 
patients were extremely diverse relative to the known out-
group species, which indicates the potential for detection of 
new species related to intestinal spirochetosis.
Conclusions
It has been casually observed for a century that stool 
from cholera patients harbors spirochete-like bacteria. We 
now deﬁ  ne the major agents present as B. pilosicoli and B. 
aalborgi. More than one third of the cholera patients had 
spirochetes in their stools at densities equal to those of V. 
cholerae. The pathophysiology of intestinal spirochetosis 
in this setting and its relevance to human health remain 
unknown. Epidemiologic analysis of intestinal spirocheto-
sis has so far relied on retrospective studies of colonic tis-
sue collected for reasons secondary to the disease (4). We 
recommend a community-based prospective study of stool 
samples from healthy persons and patients with diarrhea 
by using the techniques described herein; animal reservoirs 
should be identiﬁ  ed as a potential point of control. In the 
context of V. cholerae infection, we hypothesize that spiro-
chetes may be present before V. cholerae infection and ex-
acerbate the already devastating clinical course of cholera.
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Figure. Neighbor-joining (NJ) phylogeny of NADH oxidase (nox) 
sequences of Brachyspira pilosicoli from 5 cholera patients (A–E). 
The nox sequences were PCR ampliﬁ  ed, cloned, and sequenced 
from each patient (individual clones are appended _SX). Published 
sequences from known species are included for reference. NJ 
analysis was performed by using an NJ model and 1,000 bootstraps. 
Bootstrap values >800 are presented next to nodes. The scale bar 
indicates a 2% bp change (contiguous sequence ≈990 bp).Spirochetosis in Cholera Patients, Bangladesh
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